Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Genetics and Genetic determinism are his primary areas of study. The Attention deficit hyperactivity disorder study combines topics in areas such as Randomized controlled trial, Psychopathology, Meta-analysis, Placebo and Candidate gene. Psychiatry is closely attributed to Treatment outcome in his study.
His research in Genetics intersects with topics in Autism, School age child and Dopamine. His work carried out in the field of Genetic determinism brings together such families of science as Nuclear family, Endocrinology, Susceptibility gene, Genetic linkage and Linkage. His research integrates issues of Crossover study and Pediatrics in his study of Methylphenidate.
His primary areas of study are Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Methylphenidate and Placebo. His Attention deficit hyperactivity disorder research includes themes of Genetics, Adverse effect, Randomized controlled trial, Pediatrics and Candidate gene. Psychiatry is often connected to Tolerability in his work.
His Clinical psychology research incorporates elements of Clinical trial, Electroencephalography and Anxiety. As a part of the same scientific family, he mostly works in the field of Methylphenidate, focusing on Internal medicine and, on occasion, Single-nucleotide polymorphism. His research in Placebo intersects with topics in Anesthesia, Physical therapy and Irritability.
His main research concerns Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Electroencephalography and Audiology. James J. McGough undertakes multidisciplinary investigations into Attention deficit hyperactivity disorder and Guanfacine in his work. His biological study spans a wide range of topics, including Genome-wide association study and Pediatrics.
His Clinical psychology research includes elements of Disruptive mood dysregulation disorder, Cognition, Heritability, Genetic heterogeneity and Brain mapping. James J. McGough studied Genetic heterogeneity and Risk factor that intersect with Major depressive disorder and Comorbidity. The concepts of his Electroencephalography study are interwoven with issues in Resting state fMRI, Working memory and Cognitive psychology.
James J. McGough mostly deals with Attention deficit hyperactivity disorder, Clinical psychology, Genome-wide association study, Psychiatry and Bipolar disorder. His work carried out in the field of Attention deficit hyperactivity disorder brings together such families of science as Clinical trial, Audiology, Electroencephalography and Developmental psychology, Rating scale. The various areas that James J. McGough examines in his Clinical psychology study include Response inhibition, Young adult, Functional magnetic resonance imaging, Neural correlates of consciousness and Severity of illness.
His Genome-wide association study research incorporates themes from Temperament, Anger, Disease, Hostility and Aggression. His Bipolar disorder study integrates concerns from other disciplines, such as Schizophrenia, Psychiatric genetics and Genetic association. His Genetic association research includes themes of Heritability, Major depressive disorder, Genetic heterogeneity, Risk factor and Comorbidity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
Risperidone in Children with Autism and Serious Behavioral Problems
James T. McCracken;James McGough;Bhavik Shah;Pegeen Cronin.
The New England Journal of Medicine (2002)
Meta-Analysis of Genome-Wide Association Studies of Attention- Deficit/Hyperactivity Disorder
Benjamin M. Neale;Benjamin M. Neale;Sarah E. Medland;Sarah E. Medland;Stephan Ripke;Stephan Ripke;Philip Asherson.
Journal of the American Academy of Child and Adolescent Psychiatry (2010)
Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD.
Laurence Greenhill;Scott Kollins;Howard Abikoff;James Mccracken.
Journal of the American Academy of Child and Adolescent Psychiatry (2006)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Psychiatric Comorbidity in Adult Attention Deficit Hyperactivity Disorder: Findings From Multiplex Families
James J. McGough;Susan L. Smalley;James T. McCracken;May Yang.
American Journal of Psychiatry (2005)
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
James J. McGough;Russell A. Barkley.
American Journal of Psychiatry (2004)
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
Christopher J Mcdougle;Lawrence Scahill;Michael G. Aman;James T. Mccracken.
American Journal of Psychiatry (2005)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
Colm O'Dushlaine;Lizzy Rossin;Phil H. Lee;Laramie Duncan;Laramie Duncan.
Nature Neuroscience (2015)
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
David J. Posey;David J. Posey;Michael G. Aman;L. Eugene Arnold;Yaser Ramadan.
Archives of General Psychiatry (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: